Lonza Adds High-Potency Capacity

Lonza says it will build a plant at Visp, Switzerland to produce high-potency active pharmaceutical ingredients at large scale. The facility, which is due to cost SF80 million ($64 million), is scheduled to open in mid-2008. “The project provides Lonza with a unique competitive advantage by being the sole custom manufacturer capable of handling large-scale manufacturing in this arena,” Lonza...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers